Iris Unina Prodmetadata only
Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients
apalutamide, conventional imaging, metastatic hormone sensitive prostate cancer, new generation imaging, prostate cancer, radiographic progression free survival
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 231810
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.